Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
42.45
-0.01 (-0.02%)
At close: Apr 21, 2026, 4:00 PM EDT
42.46
+0.01 (0.02%)
After-hours: Apr 21, 2026, 5:09 PM EDT
KNSA Stock Forecast
Stock Price Forecast
The 7 analysts that cover KNSA stock have a consensus rating of "Strong Buy" and an average price target of $56, which forecasts a 31.92% increase in the stock price over the next year. The lowest target is $50 and the highest is $62.
Price Target: $56 (+31.92%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 4 | 4 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $53 → $58 | Buy | Maintains | $53 → $58 | +36.63% | Apr 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | +24.85% | Feb 25, 2026 |
| Wedbush | Wedbush | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | +24.85% | Feb 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +46.05% | Feb 19, 2026 |
| Wedbush | Wedbush | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +17.79% | Jan 13, 2026 |
Financial Forecast
Revenue This Year
932.36M
from 677.56M
Increased by 37.60%
Revenue Next Year
1.10B
from 932.36M
Increased by 17.77%
EPS This Year
1.10
from 0.75
Increased by 47.07%
EPS Next Year
1.64
from 1.10
Increased by 49.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 966.0M | 1.2B | ||||||
| Avg | 932.4M | 1.1B | ||||||
| Low | 888.9M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 42.6% | 27.3% | ||||||
| Avg | 37.6% | 17.8% | ||||||
| Low | 31.2% | 9.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.45 | 3.00 | ||||||
| Avg | 1.10 | 1.64 | ||||||
| Low | 0.71 | 1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 93.2% | 171.8% | ||||||
| Avg | 47.1% | 49.1% | ||||||
| Low | -5.9% | -1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.